In a welcome move, IQVIA Holdings stock saw its Relative Strength Rating improve from 66 to 71 on Friday.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
History reveals that the market's biggest winners tend to have an RS Rating of above 80 as they begin their largest runs. See if IQVIA Holdings stock can continue to show renewed price strength and hit that benchmark.
See How IBD Helps You Make More Money In Stocks
Is IQVIA Holdings Stock A Buy?
IQVIA Holdings stock is building a cup with handle with a 233.88 buy point. See if it can break out in volume at least 40% higher than normal.
The clinical services firm saw both earnings and sales growth rise last quarter. Earnings-per-share increased from -1% to 0%. Revenue rose from 2% to 5%.
IQVIA Holdings stock earns the No. 3 rank among its peers in the Medical-Research Equipment/Services industry group. Icon PLC and IQVIA Holdings are also among the group's highest-rated stocks.
